Going Founder Mode On Cancer - by Elliot Hershberg

kept by eddie jan 19

GitLab co-founder Sid Sijbrandij used a founder-mode strategy of maximal diagnostics and personalized therapies to achieve remission from osteosarcoma after standard care failed.

We Tested MiniMax M2.7 Against Claude Opus 4.6 - by Darko
MiniMax M2.7 scored 56.22% on SWE-Pro, matching Claude Opus 4.6 on bug and vulnerability detection at roughly 7% of the cost in practical coding tests.
also on Kilo Code
Cancer Surgery and the Pain I Didn’t Want to Face - The New York Times
After receiving a cancer diagnosis, a writer fixates on clinical medical details to avoid emotional pain, until physical symptoms force him to confront his unprocessed feelings.
also on #cancer
Uneven Frontiers (via @BenjamineYLiu)
AI will transform biopharma unevenly, with drug discovery changing sooner than later-stage clinical development.
also on #biotechnology, #healthcare
A Hundred Robots Are Running A Bio Lab - by Jolie Gan
Medra operates a bio lab run by a hundred robots that autonomously perform pharmaceutical experiments, aiming to accelerate drug discovery.
also on #biotechnology
When code is abundant
As AI makes code production cheap, the constraint moves to trusting code, requiring a durable layer of context, verification, and governance.
also on GitLab